Cytogenetic abnormalities in de novo acute myeloid leukemia in adults: Relation to morphology, age, sex and ethnicity - A single center study from Singapore

Hematology Journal

Volumn 5, Issue 5, 2004, Pages 419-425

  Enjeti, Anoop Kumar ^a   Tien, Sim Leng ^a   Sivaswaren, Christina Rudduck ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Acute myeloid leukemia; Cytogenetics; Geographic heterogeneity; Karyotype; Southeast Asia

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION 5; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 17; CONTROLLED STUDY; CYTOGENETICS; ETHNOLOGY; FEMALE; GENDER; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SINGAPORE; TRISOMY 8;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CHINA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; ETHNIC GROUPS; FEMALE; HUMANS; INDIA; INDONESIA; KARYOTYPING; LEUKEMIA, MYELOID; MALAYSIA; MALE; MIDDLE AGED; SINGAPORE;

EID: 5444260002     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200544     Document Type: Article

References (16)

1. Bloomfield CD, Goldman A, Hassfeld D, de la Chapelle A. Fourth International Workshop on Chromosomes in Leukemia 1982: clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia. Cancer Genet Cytogenet 1984; 11: 332-350.
2. Mrozek K, Heinonen K, Bloomfield CD. Clinical importance of cytogenetics in acute myeloid leukaemia. Bailliére's Best Practice Res Clin Haematol 2001; 14: 19-47.
3. Johansson B, Mertens F, Mitelman F. Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes, Chromosomes Cancer 1991; 3: 1-7.
4. Preiss BS, Kerndrup GB, Schmidt KG, Sorensen AG, Clausen NA, Gadeberg OV et al. On behalf of the AML Study Group Region of Southern Denmark. Cytogenetic findings in adult de novo acute myeloid leukaemia. A population-based study of 303/337 patients. Br J Haematol 2003; 123: 219-234.
5. Nakase K, Bradstock K, Sartor M, Gottlieb D, Byth K, Kita K et al. Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases. Leukemia 2000; 14: 163-168.
6. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-625.
7. Mitelman F (ed). (ISCN) An International System for Human Cytogenetic Nomenclature. Karger: Basel, Switzerland, 1995.
8. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000; 96: 4075-4083.
9. Mitelman F, Johansson B, Mertens F, Mitelman F. Database of Chromosome Aberrations in Cancer 2003, URL. http://cgap.nci.nih.gov/Chromosomes/Mitelman).
10. Heim S, Mitelman F (eds). Cancer Cytogenetics. Wiley-Liss: New York, 1995, pp 72-73.
11. Tien HF, Wang CH, Lin MT, Lee FY, Liu MC, Chuang SM et al Correlation of cytogenctic results with immunophenotype, genotype, clinical features and ras mutation in acute myeloid leukemia. A study of 235 Chinese patients in Taiwan. Cancer Genet Cytogenet 1995; 84: 60-68.
12. Mauritzson N, Johansson B, Albin M, Billström R, Ahlgren T, Mikoczy Z et al. A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. Eur J Haematol 1999; 62: 95-102.
13. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322-2333.
14. Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ et al. Medical Research Council Adult Leukemia Working Party. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML 11 trial. Blood 2001; 98: 1312-1320.
15. Bitter MA, Le Beau MM, Rowley JD, Larson RA, Golomb HM, Vardiman JW. Associations between morphology, karyotype and clinical features in myeloid leukemias. Hum Pathol 1987; 18: 211-225.
16. Mauritzson N, Albin M, Rylander L, Billstrom R, Ahlgren T, Mikoczy Z et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia 2002; 16: 2366-2378.